RenMab™ and RenLite™ Models Featured in GEN Magazine

In the August issue of Genetic Engineering & Biotechnology News, Biocytogen’s RenMab (fully human antibody mouse) and RenLite (common light chain) models are introduced in the article, as well as a case study using RenMab to generate timely monoclonal antibody treatment of COVID-19 infections.

Read the full article: https://www.genengnews.com/sponsored/novel-mice-models-produce-fully-human-antibodies/